Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia: Regional and diagnostic specificity

Archives of General Psychiatry

Volumn 54, Issue 7, 1997, Pages 660-669

  Glantz, Leisa A ^a   Lewis, David A ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; SYNAPTOPHYSIN;

ARTICLE; CELL DENSITY; DIAGNOSTIC ACCURACY; GRAY MATTER; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; PREFRONTAL CORTEX; SCHIZOPHRENIA; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION; VISUAL CORTEX;

EID: 0030792187     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.1997.01830190088009     Document Type: Article

References (59)

1. Levin S. Frontal lobe dysfunctions in schizophrenia, II: impairments of psychological and brain functions. J Psychiat Res. 1984;18:57-72.
2. Berman KF, Torrey EF, Daniel DG, Weinberger DR. Regional cerebral blood flow in monozygotic twins discordant and concordant for schizophrenia. Arch Gen Psychiatry. 1992;49:927-934.
3. Buchsbaum MS, Haier RJ, Potkin SG, Neuchterlein K, Bracha HS, Katz M, Lohr J, Wu J, Lottenberg S, Jerabek PA, Trenary M, Tafalla R, Reynolds C, Bunney WE Jr. Frontrostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Arch Gen Psychiatry. 1992;49:935-942.
4. Ingvar DH, Franzen G. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiat Scand. 1974;50:425-462.
5. Park S, Holzman PS. Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry. 1992;49:975-982.
6. Rubin P, Holm S, Friberg L, Videbech P, Anderson HS, Bendsen BB, Stromso N, Larsen JK, Lassen NA, Hemmingsen R. Altered modulation of pref rontal and subcortical brain activity in newly diagnosed schizophrenia and schizophreniform disorder: a regional cerebral blood flow study. Arch Gen Psychiatry. 1991;48: 987-995.
7. Wolkin A, Sanfilipo M, Wolf AP, Angrist B, Brodie JD, Rotrosen J. Negative symptoms and hypofrontality in chronic schizophrenia. Arch Gen Psychiatry. 1992; 49:959-965.
8. Weinberger DR, Berman KF, Zee RF. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia, I: regional cerebral blood flow evidence. Arch Gen Psychiatry. 1986;43:114-124.
9. Andreasen NC, Flashman L, Flaum M, Arndt S, Swayze V II, O'Leary DS, Ehrhardt JC, Yuh WT. Regional brain abnormalities in schizophrenia measured with magnetic resonance imaging. JAMA. 1994;272:1763-1769.
10. Breier A, Buchanan RW, Elkashef A, Munson RC, Kirkpatrick B, Gellad F. Brain morphology and schizophrenia: a magnetic resonance imaging study of limbic, prefrontal cortex and caudate structures. Arch Gen Psychiatry. 1992;49:921-926.
11. Schlaepfer TE, Harris GJ, Tien AY, Peng LW, Lee S, Federman EB, Chase GA, Barta PE, Pearlson GD. Decreased regional cortical gray matter volume in schizophrenia. Am J Psychiatry. 1994;151:842-848.
12. Shelton RC, Karson CN, Doran AR, Pickar D, Bigelow LB, Weinberger DR. Cerebral structural pathology in schizophrenia: evidence for a selective prefrontal cortical defect. Am J Psychiatry. 1988;145:154-163.
13. Zipursky RB, Lim KO, Sullivan EV, Brown BW, Pfefferbaum A. Widespread cerebral gray matter volume deficits in schizophrenia. Arch Gen Psychiatry. 1992; 49:195-205.
14. Wible CG, Shenton ME, Hokama H, Kikinis R, Jolesz FA, Metcalf D, McCarley RW. Prefrontal cortex and schizophrenia: a quantitative magnetic resonance imaging study. Arch Gen Psychiatry. 1995;52:279-288.
15. Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE Jr, Jones EG. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry. 1995;52:258-266.
16. Pakkenberg B. Post-mortem study of chronic schizophrenic brains. Br J Psychiatry. 1987;151:744-752.
17. Pakkenberg B. Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical disectors. Biol Psychiatry. 1993;34:768-772.
18. Selemon LD, Rajkowska G, Goldman-Rakic PS. Abnormally high neuronal density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry. 1995;52:805-818.
19. Benes FM, Davidson J, Bird ED. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch Gen Psychiatry. 1986;43:31-35.
20. Benes FM, McSparren J, Bird ED, SanGiovanni JP, Vincent SL. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry. 1991;48:996-1001.
21. Bourgeois J-P, Goldman-Rakic PS, Rakic P. Synaptogenesis in the prefrontal cortex of rhesus monkeys. Cereb Cortex. 1994;4:78-96.
22. Jahn R, Schiebler W, Ouimet C, Greengard P. A 38,000-dalton membrane protein (p38) present in synaptic vesicles. Proc Natl Acad Sci U S A. 1985;82:4137-4141.
23. Navone F, Jahn R, DiGioia G, Stukenbrok H, Greengard P, DeCamilli P. Protein p38: an integral membrane protein specific for small vesicles of neurons and neuroendocrine cells. J Cell Biol. 1986;103:2511-2527.
24. r 38,000 characteristic of presynaptic vesicles. Cell. 1985;41:1017-1028.
25. Alder J, Lu B, Valtorta F, Greengard P, Poo M. Calcium-dependent transmitter secretion reconstituted in Xenopus oocytes: requirement for synaptophysin. Science. 1992;257:657-661.
26. Alder J, Kanki H, Valtorta F, Greengard P, Poo M. Overexpression of synaptophysin enhances neurotransmitter secretion at xenopus neuromuscular synapses. J Neurosci. 1995;15:511-519.
27. Hamos JE, DeGennaro LJ, Drachman DA. Synaptic loss in Alzheimer's disease and other dementias. Neurology. 1989;39:355-361.
28. Masliah E, Terry RD, Alford M, DeTeresa R. Quantitative immunohistochemistry of synaptophysin in human neocortex: an alternative method to estimate density of presynaptic terminals in paraffin sections. J Histochem Cytochem. 1990;38:837-844.
29. Masliah E, Terry RD, Alford M, DeTeresa R, Hansen LA. Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease. Am J Pathol. 1991;138:235-246.
30. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol. 1985;42:1097-1105.
31. Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry. 1991;148:224-230.
32. Daviss SR, Lewis DA. Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons. Psychiatry Res. 1995;59:81-96.
33. Rosenberg DR, Lewis DA. Postnatal maturation of the dopaminergic innervation of monkey prefrontal and motor cortices: a tyrosine hydroxylase immunohistochemical analysis. J Comp Neurol. 1995;358:383-400.
34. Lewis DA, Campbell MJ, Terry RD, Morrison JH. The laminar and regional distribution ot neurof ibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. J Neurosci. 1987;7:1799-1808.
35. Rajkowska G, Goldman-Rakic PS. Cytoarchitectonic definition of prefrontal areas in the normal human cortex, I: remapping of areas 9 and 46 using quantitative criteria. Cereb Cortex. 1995;5:307-322.
36. Devoto SH, Barnstable CJ. SVP38: a synaptic vesicle protein whose appearance correlates closely with synaptogenesis in the rat nervous system. Ann N Y Acad Sci. 1987;493:493-496.
37. Smolen AJ. Image analytic techniques for quantification of immunohistochemical staining in the nervous system. In: Conn PM, ed. Quantitative and Qualitative Microscopy. Orlando, Fla: Academic Press Inc; 1990:208-229.
38. Perrone-Bizzozero NI, Sower AC, Bird ED, Benowitz LI, Ivins KJ, Neve RL. Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. Proc Natl Acad Sci USA. 1996;93:14182-14187.
39. Browning MD, Dudek EM, Rapier JL, Leonard S, Freedman R. Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics. Biol Psychiatry. 1993;34:529-535.
40. Eastwood SL, Harrison PJ. Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography. Neuroscience. 1995;69:339-343.
41. Peretti-Renucci R, Feuerstein C, Manier M, Lorimier P, Savasta M, Thibault J, Mons N, Geffard M. Quantitative image analysis with densitometry for immunohistochemistry and autoradiography of receptor binding sites-methodological considerations. J Neurosci Res. 1991;28:583-600.
42. Duvernoy H, Delon S, Vannson JL. Cortical blood vessels of the human brain. Brain Res Bull. 1981;7:519-579.
43. Vincent SL, McSparren J, Wang RY, Benes FM. Evidence for ultrastructural changes in cortical axodendritic synapses following long-term treatment with halopendol or clozapine. Neuropsychopharmacology. 1991;5:147-155.
44. 31Phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia. Biol Psychiatry. 1994;36:503-510.
45. Pettegrew JW, Keshavan MS, Panchalingam K, Strychor S, Kaplan DB, Tretta MG, Allen M. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics: a pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance imaging. Arch Gen Psychiatry. 1991;48:563-568.
46. Stanley JA, Williamson PC, Drost DJ, Carr TJ, Rylett RJ, Malla A, Thompson RT. An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. Arch Gen Psychiatry. 1995;52:399-406.
47. Williamson P, Drost D, Stanley J, Carr T, Morrison S, Merskey H. Localized phosphorous 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls. Arch Gen Psychiatry. 1991;48:578.
48. Glantz LA, Lewis DA. Assessment of spine density on layer III pyramidal cells in the prefrontal cortex of schizophrenic subjects. Soc Neurosci Abstr. 1995;21:239.
49. Garey LJ, Ong WY, Patel TS, Kanani M, Davis A, Hornstein C, Bauer M. Reduction in dendritic spine number on cortical pyramidal neurons in schizophrenia. Soc Neurosci Abstr. 1995;21:237.
50. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiat Res. 1982;17:319-334.
51. Hoffman RE, Dobscha SK. Cortical pruning and the development of schizophrenia: a computer model. Schizophr Bull. 1989;15:477-490.
52. Hoffman RE, McGlashan TH. Parallel distributed processing and the emergence of schizophrenic symptoms. Schizophr Bull. 1993;19:119-140.
53. Pierce JP, Lewin GR. An ultrastructural size principle. Neuroscience. 1994;58: 441-446.
54. Giguere M, Goldman-Rakic PS. Mediodorsal nucleus: areal, laminar, and tangential distribution of afferents and efferents in the frontal lobe of rhesus monkeys. J Comp Neurol. 1988;277:195-213.
55. Goldman-Rakic PS, Schwartz ML. Interdigitation of contralateral and ipsilateral columnar projections to frontal association cortex in primates. Science. 1982; 216:755-757.
56. Lund JS, Lewis DA. Local circuit neurons of developing and mature macaque prefrontal cortex: golgi and immunocytochemical characteristics. J Comp Neurol. 1993;328:282-312.
57. Sherman AD, Davidson AT, Baruah S, Hegwood TS, Waziri R. Evidence of glutamatergic deficiency in schizophrenia. Neurosci Lett. 1991;121:77-80.
58. A receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci. 1992;12:924-929.
59. A receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience. 1996;75:1021-1031.